Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
International Petroleum Corporation Announces Results of Normal Course Issuer Bid
-
Danske Bank share buy-back programme: Transactions in week 2
-
Sydbank share buyback programme: transactions in week 02
-
Alm. Brand A/S – Weekly report on share buybacks
-
Telenor appoints new members of Group Management
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results
-
Share buyback programme - week 2
-
SYNERGIA MEDICAL ANNOUNCES: FIVE PATIENTS NOW IMPLANTED WITH NAO.VNS™ LEADERSHIP CHANGE: CHARLES NOLET TO SUCCEED ATTILA BORBATH AS CEO
-
Municipality Finance issues EUR 20 million notes under its MTN programme
-
Kalmar and MCT close significant order for eco-efficient hybrid straddle carriers
-
Theta Capital announces hiring of Jeroen Tielman as Head of Institutional Relations
-
79,345 Orion Corporation A shares converted into B shares
-
Preliminary data on early redemptions (prepayments)
-
Velcan Holdings: Share Buyback Program
-
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
-
Pulsar Helium Announces Successful Completion of Deepening of the Jetstream #1 Appraisal Well, Topaz Project, Minnesota, USA
-
DTEK selects Fluence to deliver 200 MW advanced energy storage systems in Ukraine
-
Hydro acquires remaining shares in Hydrovolt
-
EUR 150 million share buyback program begins
-
Transaction in Own Shares
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 10)
-
Himax Technologies, Inc. Schedules Fourth Quarter and Full Year 2024 Financial Results Conference Call on Thursday, February 13, 2025, at 8:00 AM EST
-
McPhy revises its 2024 revenue guidance to approximately 11m€
-
ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Novartis Entresto® US patent upheld by US Court of Appeals
-
Idorsia to call for a bondholder meeting
-
Start of Day Message
-
Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
-
argenx Highlights 2025 Strategic Priorities
-
Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma
-
DEME secures contract for foundation and offshore substation installation at Fengmiao 1 offshore wind farm in Taiwan
-
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
-
W&T Offshore Announces Proposed Senior Second Lien Notes Offering
-
Prestigious Scientific Event: Hong Kong Laureate Forum 2025
-
Heihe Cold-Area Car Testing Index Released: Anchoring Global Innovation Hubs, Showcasing the Thriving Power of the Industry
-
PACS Investors Have Opportunity to Lead PACS Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
Dr. Yorell Manon Matos Launches Transformative Healthcare Education Grant to Cultivate Next Generation of Medical Innovators
-
Dr. Kerry Evans Award for Nursing Students: Scholarship Supporting the Future of Compassionate Patient Care
-
Stuart Piltch Grant for Tech Innovators Concludes Accepting New Applications
-
Dr. Abeer AbouYabis Scholarship for Future Doctors Inspires Aspiring Physicians to Tackle Healthcare Challenges
-
Dr. Wade Newman Grant for Healthcare Students Opens Applications to Foster Future Leaders in Patient Care
-
Scottsdale Arizona’s Luke Johnson Launches Scholarship for Aspiring Entrepreneurs to Drive Innovation across the U.S.
-
Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities
-
Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs
-
Arowana recognised among Real Leaders’ Top Impact Companies for 2025
-
Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025
-
Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference
-
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
